UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study)

Barnett, AH; Millar, HL; Loze, J.-, Y; L'Italien, GJ; van Baardewijk, M; Knapp, M; (2009) UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study). European archives of psychiatry and clinical neuroscience, 259 (4). pp. 239-247. ISSN 0940-1334 DOI: https://doi.org/10.1007/s00406-008-0863-2

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1007/s00406-008-0863-2

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar